Page 8 - Alkermes News Today

Alkermes (NASDAQ:ALKS – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share guidance of 2.800-2.800 for the period, compared to the consensus earnings per share estimate of 2.520. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate […]

Alkermes plans to initiate phase 2 trials for its orexin-2 receptor agonist aimed at treating narcolepsy within the first half of the year.

Alkermes (NASDAQ:ALKS – Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.51 by ($0.29), RTT News reports. The company had revenue of $377.50 million for the quarter, compared to the consensus estimate of $362.78 million. Alkermes had […]

Alkermes ( NASDAQ:ALKS ) Full Year 2023 Results Key Financial Results Revenue: US$1.66b (up 50% from FY 2022). Net...

Alkermes shows rising price performance, earning an upgrade to its IBD Relative Strength Rating The post Alkermes Stock Gets RS Rating Upgrade; Profits Surge…

Alkermes plc (NASDAQ:ALKS) Q4 2023 Earnings Call Transcript February 15, 2024 Alkermes plc misses on earnings expectations. Reported EPS is $0.22 EPS, expectations were $0.46. Alkermes plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. And welcome to the […]

Robust Revenue Growth and Strategic Focus Propel Alkermes Into 2024

Most readers would already be aware that Alkermes' (NASDAQ:ALKS) stock increased significantly by 20% over the past...

Alkermes (NASDAQ:ALKS – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.22 earnings per share for the quarter, missing analysts’ consensus estimates of $0.51 by ($0.29), RTT News reports. Alkermes had a net margin of 13.50% and a return on equity of 11.41%. During the same quarter in the previous […]

Shares of Alkermes plc (NASDAQ:ALKS – Get Free Report) rose 7.2% during trading on Thursday . The stock traded as high as $30.40 and last traded at $30.00. Approximately 759,412 shares changed hands during mid-day trading, a decline of 49% from the average daily volume of 1,484,791 shares. The stock had previously closed at $27.99. […]